Tag Archives: NYSE:MD

Mednax Inc (MD) Receives a Sell from UBS

UBS analyst Whit Mayo maintained a Sell rating on Mednax Inc (MD – Research Report) today and set a price target of $18.00. The company’s shares closed last Monday at $23.72, close to its 52-week low of $19.93. According to

Credit Suisse Thinks Mednax Inc’s Stock is Going to Recover

In a report released today, A.J. Rice from Credit Suisse maintained a Buy rating on Mednax Inc (MD – Research Report), with a price target of $42. The company’s shares opened today at $34.48, close to its 52-week low of

Mednax Inc (MD) Gets a Hold Rating from Mizuho Securities

Mizuho Securities analyst Ann Hynes reiterated a Hold rating on Mednax Inc (MD – Research Report) on January 25 and set a price target of $38. The company’s shares opened today at $36.70, close to its 52-week low of $31.68.

SunTrust Robinson Keeps Their Hold Rating on Mednax Inc (MD)

SunTrust Robinson analyst David S Macdonald reiterated a Hold rating on Mednax Inc (MD – Research Report) on November 5 and set a price target of $44. The company’s shares closed yesterday at $39.48, close to its 52-week low of

Stephens Keeps a Buy Rating on Mednax Inc (MD)

In a report issued on November 2, Dana Hambly from Stephens reiterated a Buy rating on Mednax Inc (MD – Research Report), with a price target of $45. The company’s shares closed on Friday at $39.24, close to its 52-week

Mizuho Securities Reiterates a Hold Rating on Mednax Inc (MD)

In a report issued on November 2, Ann Hynes from Mizuho Securities reiterated a Hold rating on Mednax Inc (MD), with a price target of $43. The company’s shares closed on Friday at $39.24, close to its 52-week low of